Initiator Pharma Q4’21: Steady Progression - Redeye

Redeye leaves a comment on the Q4 report Initiator Pharma released earlier this morning. With its three programs now in clinical trials, we are encouraged by the company's progress, building up for exciting times ahead.

Länk till analysen i sin helhet: https://www.redeye.se/research/833712/initiator-pharma-q421-steady-progression?utm_source=finwire&utm_medium=RSS